These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1185 related items for PubMed ID: 18836338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Targeted therapy for metastatic renal cell carcinoma.
    Motzer RJ, Bukowski RM.
    J Clin Oncol; 2006 Dec 10; 24(35):5601-8. PubMed ID: 17158546
    [Abstract] [Full Text] [Related]

  • 6. Targeted Therapy for Metastatic Renal Cell Carcinoma.
    Afriansyah A, Hamid AR, Mochtar CA, Umbas R.
    Acta Med Indones; 2016 Oct 10; 48(4):335-347. PubMed ID: 28143997
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Medical treatment of renal cell carcinoma].
    Guy L, Bay JO, Bastide C, Mahammedi H, Bruyere F, Karsenty G.
    Prog Urol; 2013 Nov 10; 23(15):1225-37. PubMed ID: 24183081
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma.
    Rini BI.
    Cancer; 2009 May 15; 115(10 Suppl):2306-12. PubMed ID: 19402073
    [Abstract] [Full Text] [Related]

  • 11. Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy.
    Calvo E, Schmidinger M, Heng DY, Grünwald V, Escudier B.
    Cancer Treat Rev; 2016 Nov 15; 50():109-117. PubMed ID: 27664394
    [Abstract] [Full Text] [Related]

  • 12. Major treatment improvements encourage kidney cancer researchers to seek further gains.
    Tuma RS.
    J Natl Cancer Inst; 2008 Sep 03; 100(17):1202-3. PubMed ID: 18728277
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma.
    Fernández-Pello S, Hofmann F, Tahbaz R, Marconi L, Lam TB, Albiges L, Bensalah K, Canfield SE, Dabestani S, Giles RH, Hora M, Kuczyk MA, Merseburger AS, Powles T, Staehler M, Volpe A, Ljungberg B, Bex A.
    Eur Urol; 2017 Mar 03; 71(3):426-436. PubMed ID: 27939075
    [Abstract] [Full Text] [Related]

  • 17. New therapeutic approaches in the management of metastatic renal cell carcinoma.
    Gkialas IK, Papadopoulos G.
    J BUON; 2009 Mar 03; 14(3):399-404. PubMed ID: 19810129
    [Abstract] [Full Text] [Related]

  • 18. Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnel.
    Pouessel D, Culine S.
    Expert Rev Anticancer Ther; 2006 Dec 03; 6(12):1761-7. PubMed ID: 17181490
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.